FIV gp120 Antibodies

Santa Cruz Biotechnology offers a broad range of FIV gp120 monoclonal antibodies for research in feline immunodeficiency virus (FIV) studies. FIV gp120 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FIV gp120 is a critical envelope glycoprotein that plays a significant role in the virus's ability to infect host cells by facilitating attachment and entry. Understanding FIV gp120 function is essential for developing therapeutic strategies and vaccines against FIV, which poses a serious health risk to domestic cats. The study of FIV gp120 provides valuable insights into the mechanisms of viral pathogenesis and immune evasion. Research focusing on FIV gp120 has revealed important parallels with HIV infection in humans, making it an excellent model for studying retroviral infections. Investigating FIV gp120 helps advance knowledge about viral entry mechanisms and potential therapeutic targets. Characterization of FIV gp120 has contributed significantly to understanding host-pathogen interactions in feline viral diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of FIV and improving feline health outcomes.